Back to mobile site

H.C. Wainwright Reiterates Buy Rating on Clearside Biomedical (CLSD)

August 28, 2024 6:48 AM EDT Send to a Friend
H.C. Wainwright analyst Yi Chen reiterated a Buy rating and $5.00 price target on Clearside Biomedical (NASDAQ: CLSD).The analyst commented ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login